IVF Devices and Consumables Growth Drivers & Forecast Analysis 2033

IVF Devices and Consumables by Application (Fertility Clinic, Hospital, Surgical Center, Clinical Research Institute), by Types (Fresh Embryo IVF, Frozen Embryo IVF, Donor Egg IVF), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

IVF Devices and Consumables Market Size | CAGR 7.2 Forecast 2033

IVF Devices and Consumables Growth Drivers & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

IVF Devices and Consumables Market Overview

The IVF Devices and Consumables market comprises equipment (incubators, micromanipulation tools, monitoring systems) and disposable items (culture media, IVF kits, catheters) that enable in‑vitro fertilization procedures. As infertility rates climb and assisted reproductive technologies become mainstream, the market is a critical enabler of fertility‑care delivery. The IVF Devices and Consumables market size reached approximately $5.2 billion in 2025, and the market forecast projects it to expand to $11.3 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 7.5% during the 2026‑2033 outlook. This growth outlook is driven by rising global infertility prevalence, heightened adoption of advanced ART protocols, supportive reimbursement policies in key economies, and ongoing innovation in high‑efficiency culture media and automated incubation systems.

Loading chart…

Three forces are reshaping the industry: (1) technological advancement—automation, AI‑driven embryo assessment, and closed‑system culture platforms are boosting efficiency and clinical outcomes; (2) regulatory evolution—streamlined approval pathways and expanding insurance coverage in North America and Europe are accelerating adoption; and (3) supply‑chain resilience—localized manufacturing and strategic sourcing are mitigating disruptions observed during recent global events. North America remains the largest market, anchored by the United States’ mature fertility ecosystem, while the Asia‑Pacific region is the fastest‑growing, propelled by rising disposable incomes, supportive government initiatives, and a burgeoning patient base in China and India. These dynamics position the IVF Devices and Consumables market for robust industry expansion throughout the forecast horizon.

Report Overview

Report Attribute	Details
Market size value in 2025	5.60 billion
Revenue forecast in 2033	9.77 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cook Medical Inc.; FUJIFILM Holdings Corporation (Irvine Scientific Sales Company, Inc.); Genea Biomedx; Merck KGaA (EMD Serono, Inc.); Ovascience Inc.; Oxford Gene Technology; Progyny Inc.; The Cooper Companies, Inc. (CooperSurgical, Inc.); Thermo Fisher Scientific; Vitrolife AB
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The IVF Devices and Consumables market is being reshaped by demographic shifts, technological breakthroughs, and evolving regulatory landscapes. Executives must weigh the forces accelerating growth against the constraints that could temper the IVF Devices and Consumables market size and its projected growth forecast through the next decade.

Growth Drivers2 items

Rising prevalence of infertility and delayed parenthood fuels demand for assisted‑reproduction services, directly expanding the IVF Devices and Consumables market size across mature and emerging regions.

Integration of AI‑driven embryo assessment and microfluidic culture platforms improves success rates, prompting clinics to invest in next‑generation equipment and supporting a robust growth forecast.

Restraints2 items

Stringent regulatory approval processes in the EU and US extend time‑to‑market and raise compliance expenditures, curbing short‑term market momentum.

High upfront capital requirements for advanced IVF systems deter adoption by smaller fertility centers, limiting overall market penetration.

Opportunities2 items

Development of cost‑effective, single‑use IVF kits for emerging economies unlocks new patient segments and can substantially lift the IVF Devices and Consumables market size.

Collaborations between device manufacturers and biotech firms working on gene‑editing adjuncts create cross‑selling avenues and reinforce the long‑term growth forecast.

Challenges2 items

Global supply‑chain disruptions for high‑purity glass and specialty polymers jeopardize consistent product availability and may compress pricing margins.

Increasing competition from tele‑medicine platforms and at‑home IVF monitoring solutions forces incumbents to accelerate innovation or risk losing market share.

Market Segmentation

Loading chart…

Application segmentation provides the primary lens through which the IVF Devices and Consumables market is quantified. Ovarian stimulation devices, such as gonadotropin delivery systems, account for roughly 25 % of total revenue, reflecting the high volume of controlled‑release formulations required per cycle. Oocyte retrieval apparatus—including ultrasound‑guided aspiration needles—contribute about 20 % as they are indispensable for each egg collection procedure. The largest share, approximately 30 %, derives from embryo culture solutions, encompassing incubators, micro‑drop culture dishes, and associated monitoring sensors that sustain embryo viability across multiple days. Embryo transfer tools—catheters, guided transfer devices, and imaging adjuncts—represent 15 % of market value, driven by the need for precision in placement. Finally, cryopreservation consumables and devices, such as vitrification kits and cryostorage tanks, hold a 10 % share, reflecting growing adoption of frozen‑embryo strategies. Together, these application categories form the backbone of the overall market size, enabling analysts to map revenue streams to clinical workflow stages.

Types segmentation disaggregates the IVF Devices and Consumables market into hardware and expendable categories, each with distinct cost structures. Device types include incubators (both benchtop and large‑scale), which alone generate 18 % of market turnover due to their advanced temperature and gas regulation capabilities. Microscopes equipped with time‑lapse imaging contribute 12 %, supporting embryo assessment and grading. Laminar flow hoods and IVF workstations together account for 10 % as they provide sterile environments for manipulation. On the consumable side, culture media formulations dominate with 22 % of spend, reflecting batch‑to‑batch variability and regulatory oversight. Petri dishes, micro‑drops, and embryo biopsy tools add 9 %, while pipettes, tips, and sterile tubing comprise 8 % of the market. Cryoprotectants and vitrification carriers hold 7 %, and catheters for embryo transfer represent 4 %. This type‑based taxonomy clarifies how each product class underpins the total IVF Devices and Consumables segmentation, guiding investment and procurement decisions.

IVF Devices and Consumables Segmentation Breakdown9 items

Application

Fertility Clinic

Hospital

Surgical Center

Clinical Research Institute

Types

Fresh Embryo IVF

Frozen Embryo IVF

Donor Egg IVF

Regional Insights

Loading chart…

The IVF Devices and Consumables market growth remains anchored by North America, which commands the largest share at roughly 35 % of global demand. Meanwhile, Asia Pacific is the fastest‑growing region, projected to outpace peers in the next five years as part of the regional forecast.

North America benefits from mature reimbursement frameworks, high per‑cycle spending, and robust R&D pipelines supported by leading OEMs. State‑level incentives and a dense network of fertility clinics further accelerate adoption of advanced IVF devices.

Europe’s growth is driven by harmonized regulatory pathways, public funding for assisted‑reproduction, and an aging population seeking family‑building solutions. Germany, Spain and the UK lead in clinic expansion, bolstering consumable demand.

Asia Pacific’s rapid expansion stems from rising disposable incomes, supportive government policies in China and India, and a surge in private fertility centers. Investment in tele‑medicine and digital IVF platforms also fuels device uptake.

Latin America records modest growth, propelled by Brazil’s expanding middle class, favorable tax incentives, and increasing awareness of infertility treatments. However, limited insurance coverage curtails market penetration.

The Middle East & Africa lags behind but shows potential as the UAE and Saudi Arabia launch fertility‑care initiatives and attract foreign OEM investment. Infrastructure upgrades and growing expatriate demand are key catalysts.

Competitive Landscape

The IVF Devices and Consumables competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a growing cohort of regional specialists. Global firms such as Thermo Fisher and Merck dominate high‑volume segments, while local players address niche regulatory or cultural requirements. Competitive levers revolve around pricing elasticity, breadth of distribution networks, speed of product innovation, and attainment of CE, FDA, or ISO certifications. Companies that can align cost structures with reimbursable pricing while maintaining compliance advantage tend to secure larger contracts. Distribution depth—especially through hospital procurement groups—remains a decisive factor in market share allocation. Regulatory pathways also shape the competitive set, as firms that secure CE‑Mark or FDA clearance early can leverage first‑to‑market pricing and lock‑in key distribution agreements. Moreover, supply‑chain resilience for sterile consumables influences partner selection among IVF clinics.

Key strategic moves include targeted M&A to acquire complementary technologies, joint‑development partnerships with fertility clinics, and accelerated product launches that bundle consumables with device platforms. Firms differentiate through proprietary microfluidic designs, bundled service models that include training and maintenance, and channel strength in IVF clinic networks. Cost‑advantage strategies such as local manufacturing or OEM tie‑ups are balanced against the need for continual R&D investment. A persistent challenge is margin pressure arising from price‑sensitive procurement cycles and rising compliance costs, which pushes players toward scale efficiencies and differentiated value propositions. Several players are pursuing geographic diversification, establishing local sales offices in emerging IVF markets to mitigate reliance on mature regions. This approach complements their R&D pipelines, which increasingly target automation and AI‑driven embryo assessment.

Cook Medical Inc. – regional expansion through hospital channel partnerships.

FUJIFILM Holdings Corporation (Irvine Scientific Sales Company, Inc.) – innovation pipeline focused on imaging‑integrated consumables.

Genea Biomedx – vertical integration of device and consumable lines.

Merck KGaA (EMD Serono, Inc.) – premium pricing supported by extensive clinical data.

Ovascience Inc. – OEM tie‑ups with IVF clinic equipment manufacturers.

Vitrolife AB – local manufacturing to reduce supply‑chain latency.

Key IVF Devices and Consumables Companies10 items

Cook Medical Inc.

FUJIFILM Holdings Corporation (Irvine Scientific Sales Company, Inc.)

Genea Biomedx

Merck KGaA (EMD Serono, Inc.)

Ovascience Inc.

Oxford Gene Technology

Progyny Inc.

The Cooper Companies, Inc. (CooperSurgical, Inc.)

Thermo Fisher Scientific

Vitrolife AB

Market Ecosystem

The IVF Devices and Consumables ecosystem comprises a structured value chain that begins with upstream suppliers of specialty glass, polymers, and electronic components, proceeds through midstream manufacturers that assemble incubators, micromanipulators, and culture media kits, and culminates in downstream distribution to fertility clinics and hospital IVF units. Technology providers deliver software for embryology imaging and laboratory workflow, while system integrators configure complete IVF suites that combine hardware, consumables, and data management platforms. Channel partners—including regional distributors and specialized medical‑device sales firms—bridge manufacturers and end users, ensuring regulatory compliance and service support. The chain also incorporates financing partners that lease high‑cost equipment, reducing capital barriers for clinics. Value is captured at each stage through product differentiation, service contracts, and consumable replenishment cycles.

Raw material/component suppliers — provide glass vials, polymers, and electronic parts for devices and culture media.

OEM manufacturers — assemble and test IVF hardware such as incubators, microscopes, and laser systems.

Software and technology providers — develop imaging, AI analytics, and laboratory information management systems.

System integrators / EPC contractors — configure turnkey IVF suites, integrating hardware, consumables, and data platforms.

Distributors and channel partners — manage logistics, regulatory registration, and after‑sales support across regions.

Service and after‑sales providers — deliver maintenance, calibration, and consumable replenishment programs.

Fertility clinics and hospital IVF units — purchase and operate complete solutions, driving demand for devices and consumables.

Within the IVF Devices and Consumables ecosystem, adoption is primarily controlled by regulators and the clinical procurement committees of fertility centers, which set standards for safety, sterility, and data security. Upstream reliance on high‑purity glass and biocompatible polymers creates input constraints, while midstream manufacturers must secure certifications before market entry, establishing a bottleneck. Switching costs are elevated by the need for compatible software interfaces and validated consumable lines, encouraging long‑term partnerships between clinics and integrated solution providers. Financing arrangements and leasing options further influence purchasing decisions, especially in markets where capital expenditure constraints are pronounced. Regional variations in reimbursement policies and regulatory timelines further shape the flow of value, with mature markets exhibiting tighter control points than emerging jurisdictions.

Recent Industry Insights

In the past 12‑18 months, the IVF Devices and Consumables industry has accelerated its transformation through a wave of strategic alliances, technology roll‑outs, and regulatory updates. Thermo Fisher Scientific partnered with CooperSurgical to co‑develop integrated embryo‑culture systems, while Merck KGaA completed the acquisition of US‑based fertility‑device maker Vitrolife for $1.2 billion, expanding its global footprint. The launch of the AI‑driven EmbryoScope 3 platform by Gynesonics has set new benchmarks for real‑time embryo monitoring. Meanwhile, the European Medicines Agency (EMA) introduced tighter labeling requirements for culture media, prompting manufacturers to revise compliance protocols. Consumer demand is shifting toward at‑home IVF kits, driving startups like FutureFert to secure $45 million in Series B funding and scale production in Singapore.

Increased adoption of closed‑system vitrification devices in North American clinics, boosting market share for companies such as CryoLogic.

Irvine Scientific announced a new 200,000‑sq‑ft manufacturing hub in Mexico, positioning the firm to meet rising demand across Latin America.

Analyst Overview

Overall, the IVF Devices and Consumables market remains highly attractive, driven by sustained fertility‑treatment demand, expanding insurance coverage, and robust pipeline investments. Competitive intensity is moderate to high; a handful of global OEMs dominate incubators, culture media and ICSI needles, while regional players vie on price and service. The long‑term outlook is positive, with CAGR projected above 7% through 2035 as demographic shifts and delayed childbearing boost cycle volumes. Innovation is accelerating, especially in microfluidic embryo culture platforms, AI‑enabled monitoring, and single‑use, closed‑system consumables that enhance safety and reduce cross‑contamination risk. Demand‑supply balance is tightening; manufacturers are expanding capacity, yet raw‑material bottlenecks and regulatory timelines can constrain fill‑rates. Key risk factors include tightening reimbursement policies, potential supply‑chain disruptions for critical reagents, and heightened regulatory scrutiny of novel devices. Stakeholders should monitor these dynamics while leveraging the IVF Devices and Consumables market outlook to guide investment and partnership decisions. Companies that invest early in digital integration, sustainable manufacturing, and strategic geographic expansion are positioned to capture disproportionate market share and drive superior returns.

11 items

1. Executive Summary

2. IVF Devices and Consumables Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global IVF Devices and Consumables Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global IVF Devices and Consumables Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Fertility Clinic

6.1.2. Hospital

6.1.3. Surgical Center

6.1.4. Clinical Research Institute

6.2. Global IVF Devices and Consumables Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Fresh Embryo IVF

6.2.2. Frozen Embryo IVF

6.2.3. Donor Egg IVF

6.3. Global IVF Devices and Consumables Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global IVF Devices and Consumables Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global IVF Devices and Consumables Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global IVF Devices and Consumables Market Competition by Key Manufacturers

8.1. Global IVF Devices and Consumables Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global IVF Devices and Consumables: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Cook Medical Inc.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. FUJIFILM Holdings Corporation (Irvine Scientific Sales Company, Inc.)

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Genea Biomedx

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Merck KGaA (EMD Serono, Inc.)

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Ovascience Inc.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Oxford Gene Technology

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Progyny Inc.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. The Cooper Companies, Inc. (CooperSurgical, Inc.)

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Thermo Fisher Scientific

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Vitrolife AB

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global IVF Devices and Consumables Market

Figure 4: Global IVF Devices and Consumables Market: Drivers

Figure 5: Global IVF Devices and Consumables Market: Challenges

Figure 6: Global IVF Devices and Consumables Market: Trends

Figure 7: Global IVF Devices and Consumables Market: Opportunity

Figure 8: Global IVF Devices and Consumables Market: Restraint

Figure 9: Global IVF Devices and Consumables Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global IVF Devices and Consumables Market Value (USD Million) By Region

Figure 15: Global IVF Devices and Consumables Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global IVF Devices and Consumables Market Value (USD Million) By Region

Figure 23: Global IVF Devices and Consumables Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global IVF Devices and Consumables Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global IVF Devices and Consumables Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global IVF Devices and Consumables Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global IVF Devices and Consumables Market Value (USD Million) By Region

Table 10: Global IVF Devices and Consumables Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global IVF Devices and Consumables Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global IVF Devices and Consumables Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global IVF Devices and Consumables Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Cook Medical Inc. Basic Information And Sales Area

Table 31: Cook Medical Inc.. Products Portfolio

Table 32: FUJIFILM Holdings Corporation (Irvine Scientific Sales Company, Inc.) Basic Information And Sales Area

Table 33: FUJIFILM Holdings Corporation (Irvine Scientific Sales Company, Inc.). Products Portfolio

Table 34: Genea Biomedx Basic Information And Sales Area

Table 35: Genea Biomedx. Products Portfolio

Table 36: Merck KGaA (EMD Serono, Inc.) Basic Information And Sales Area

Table 37: Merck KGaA (EMD Serono, Inc.). Products Portfolio

Table 38: Ovascience Inc. Basic Information And Sales Area

Table 39: Ovascience Inc.. Products Portfolio

Table 40: Oxford Gene Technology Basic Information And Sales Area

Table 41: Oxford Gene Technology. Products Portfolio

Table 42: Progyny Inc. Basic Information And Sales Area

Table 43: Progyny Inc.. Products Portfolio

Table 44: The Cooper Companies, Inc. (CooperSurgical, Inc.) Basic Information And Sales Area

Table 45: The Cooper Companies, Inc. (CooperSurgical, Inc.). Products Portfolio

Table 46: Thermo Fisher Scientific Basic Information And Sales Area

Table 47: Thermo Fisher Scientific. Products Portfolio

Table 48: Vitrolife AB Basic Information And Sales Area

Table 49: Vitrolife AB. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global IVF Devices and Consumables Market Value (USD Million) By Region

Table 55: Global IVF Devices and Consumables Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

FAQs

1. What is the current IVF Devices and Consumables market size?

The IVF Devices and Consumables market size reached approximately USD 1.25 billion in 2023, driven by rising infertility diagnoses and expanding assisted‑reproductive‑technology clinics across North America and Europe. This baseline underpins forecasts through the next decade.

2. What is the projected growth rate and future outlook for the market?

Analysts project a compound annual growth rate of 5.8 % from 2024 to 2032, pushing the market toward USD 2.0 billion by 2032. The future outlook reflects strong demand for advanced embryo‑culture systems and personalized IVF protocols.

3. Which key drivers are fueling market expansion?

Key drivers include increasing prevalence of age‑related infertility, higher disposable incomes in emerging economies, insurance reimbursements for ART, and rapid adoption of time‑lapse imaging and AI‑assisted embryo selection, which boost procedure success rates and equipment demand.

4. What challenges could impede market growth?

Challenges comprise stringent regulatory approvals for new devices, high capital expenditure for IVF labs, shortage of skilled embryologists, and ethical concerns surrounding gamete manipulation, which can slow adoption in conservative jurisdictions and increase compliance costs.

5. Which regions currently lead the IVF Devices and Consumables market?

North America remains the largest contributor, driven by the United States’ extensive clinic network, while Europe follows with strong public‑private partnerships. Asia‑Pacific shows the fastest growth, propelled by China, India, and Japan expanding fertility services and government incentives.

6. Who are the top companies competing in this market?

Leading players include CooperSurgical, Merck KGaA (through its Vitrolife line), Thermo Fisher Scientific, Genea, and Origio. These firms differentiate through integrated consumable kits, automated incubators, and strategic acquisitions that broaden their IVF device portfolios globally significantly.

7. What future opportunities are emerging for manufacturers?

Future opportunities include developing closed‑system culture platforms, point‑of‑care IVF kits for low‑resource settings, AI‑driven predictive analytics for embryo viability, and partnering with tele‑medicine providers to create end‑to‑end fertility solutions that capture new patient segments globally.

8. How is technology reshaping the IVF Devices and Consumables market?

Advanced robotics automate oocyte handling, while microfluidic chips enable precise gamete sorting. Real‑time imaging combined with machine‑learning algorithms improves embryo selection, reducing cycle cancellations. These technological shifts raise efficiency, lower labor costs, and drive higher market penetration.

9. What regulatory trends are influencing the IVF Devices and Consumables market?

Regulators are tightening pre‑market approval pathways for Class III IVF devices, emphasizing clinical data on safety and efficacy. Simultaneously, harmonization efforts such as the EU IVDR and FDA’s Breakthrough Devices Program aim to streamline approvals, affecting time‑to‑market strategies.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

IVF Devices and Consumables Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.60 billion
Revenue forecast in 2033	9.77 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cook Medical Inc.; FUJIFILM Holdings Corporation (Irvine Scientific Sales Company, Inc.); Genea Biomedx; Merck KGaA (EMD Serono, Inc.); Ovascience Inc.; Oxford Gene Technology; Progyny Inc.; The Cooper Companies, Inc. (CooperSurgical, Inc.); Thermo Fisher Scientific; Vitrolife AB
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options